Associate Editor

Arnon Blum, MD

Director of Medicine
Department of Medicine
Baruch Padeh Poria Medical Center affiliated to the Faculty of Medicine
Bar-Ilan University
Ramat Gan, 5290002, Israel


Dr. Blum received his MD at the Technion, specialized in Internal Medicine at Hebrew University, and then in Cardiology at Tel-Aviv University. He served in the IDF as a Flight Surgeon (Lieutenant Colonel). Since 1999 Prof. Dr. Blum has been the Director of the Internal Medicine Ward at Baruch Padeh Medical Center—Poriya, Tiberias. Dr. Blum further concentrated on Vascular Biology and Vascular Stem Cell research, receiving his training at the National Institutes of Health (Bethesda, MD, USA; 1997-1999 and 2006-2008) exploring means for cardio-vascular regeneration. In 2011-12, he was invited as a visiting Professor to lead a clinical trial at the University of Miami for adult (mesenchymal) stem cell transplants to patients with severe heart failure. There, he discovered a key mechanism that explains the beneficial effects of cell transplantation to the failing heart.
Dr. Blum is the incoming Director of Internal Medicine Department in the Faculty of Medicine, and a member of 5 steering committees at Bar-Ilan University School of Medicine in the Galilee. His main goal now is to build a Center of Excellence in Regenerative Medicine at the School of Medicine in the Galilee, which will focus on cardiovascular regeneration and include basic research and clinical facilities.

Research Interest

His research interest includes: Endothelial Progenitor Stem Cell Research, Endothelial Function and Vascular Biology, Heart Failure and Preventive Cardiology, Stem Cell Transplantation for Cardiovascular Disease.

Scientific Activities


• (1995) Winner of the Henri Neufeld Research Award
• (1997) Winner of the Kellerman Research Award for Young Scientists
• (2004) Winner of the Best Clinical Research Competition/Meeting of the Israeli, Society for Research, Prevention, and Treatment of Atherosclerosis
• (2004) Teva-Danone Award
• (2013) Excellence Grant in Cardiovascular Research-Diabetes and Stem Cells, Bar Ilan University


• (2001) Israeli Internal Medicine Society
• (1999) Israeli Clinical Cardiology in the Community
• (1999) Israeli Intensive Cardiac Care
• (1996) Israeli Heart Association
• (1995) Israeli Association of Transplantation
• (1994) International Society of Heart Research- European Section
• (1988) Israeli Allergy and Clinical Immunology Society



1. Kraus Y, Blum A, Rubinov A Hyperthyroidism and systemic lupus erythematosus: chance or genetic predisposition? Clinical and Exp Rheum 1991; 9(4): 438-440
2. Blum A, Rubinov A, Galun E Predominance of renal involvement in male SLE patients compared to females Clinical and Exp Rheum 1991; 9(2): 206-208
3. Rechavia E, Blum A, Mager A, Strasberg B, Sclarovsky S Electrocardiographic Q waves Inconstancy during Thrombolysis in Acute Anterior Myocardial Infarction Cardiology 1992; 80(5-6): 392-398
4. Levy M, Blum A, Caraco Y, Granit L, Zylber-Katz E The Pharmacokinetics of the Dipyrone Product 4-Methylaminoantipyrine in Patients with Liver Cirrhosis Drug Investigation 101007/BF03258402
5. Birnbaum Y, Sclarovsky S, Blum A, Strasberg B Prognostic significance of the initial ECG pattern in patients with a first anterior myocardial infarction Chest 1993; 103(6): 1681-1687
6. Blum A, Rechavia E, Sclarovsky S Infective myocardial infarction Chest 1993; 103: 1084-1086
7. Blum A, Sclarovsky S, Rehavia E, Shohat B -lymphocyte subpopulations and Interleukin-1 beta and soluble Interleukine-2 ReceptorIn Acute Myocardial Infarction American Heart J 1994; 127: 1226-1230
8. Blum A, Shohat B, Sclarovsky ST -lymphocyte activation instable angina pectoris and following PTCA. Circulation. 1995; 91: 20-22
9. Blum A, Vardinon N, Kaplan G, Laniado S, Yust I, Miller H. Autoimmune and inflammatory responses might have an additive effect in post percutaneous transluminal coronary angioplasty (PTCA) restenosis The American Journal of Cardiology 81(3): 339-341, 1998
10. Blum A, Giladi M, Weinberg M, et al. High anti-cytomegalovirus (CMV) IgG antibody titer may characterize coronary artery disease patients and might predict post coronary balloon angioplasty restenosis. The American Journal of Cardiology. 1998; 81(7): 866-868. doi: 10.1016/S0002-9149(98)00019-8
11. Blum A, Vardinon N, Kaplan G, Laniado S, Yust I, Miller H. Serum Amyloid Type A (SAA) may be a predictor of restenosis. Clinical Cardiology. 1998; 21: 655-658. doi: 10.1002/clc.4960210909
12. Blum A, Porat R, Rosenschein U, et al. Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris. The American Journal of Cardiology. 1999; 83(10): 1488-1490. doi: 10.1016/S0002-9149(99)00129-0
13. Kon Koh K, Blum A, Hathaway L, Mincemoyer R. Vascular Effects of Estrogen and Vitamin E Therapies in Postmenopausal Women. Circulation. 1999; 100: 1851-1857. doi: 10.1161/01.CIR.100.18.1851
14. Blum A, Hathaway L, Mincemoyer R, et al. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women. Journal of the American College of Cardiology. 2000; 35(2): 271-276. doi: 10.1016/S0735-1097(99)00553-7
15. Blum A, Cannon RO III, Costillo R, Schenke WH, Csako G. Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women. Journal of Laboratory and Clinical Medicine. 2000; 135(3): 231-237.doi: 10.1067/mlc.2000.104909
16. Blum A, Hathaway L, Mincemoyer R, Schenke W, Csako G, Cannon RO III. Oral L-arginine in patients with coronary artery disease on medical management. Circulation. 2000; 101(18): 2160-2164, 2000 doi: 10.1161/01.CIR.101.18.2160
17. Blum A, Schenke WH, Hathaway L, et al. Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women. The American Journal of Cardiology. 2000; 86(8): 892-895. doi: 10.1016/S0002-9149(00)01116-4
18. Blum A, Hathaway L, Mincemoyer R, et al. Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men. The American Journal of Cardiology. 2000; 85(12): 1491-1494. doi: 10.1016/S0002-9149(00)00802-X
19. Blum A, Lupovitch S, Khazim K, Peleg A, Gumanovsky A, Jawabreh S. Homocysteine levels in patients with risk factors to atherosclerosis. Clinical Cardiology. 24 (6): 463-466, 2001 doi: 10.1002/clc.4960240609
20. Ardans JA, Blum A, Mangan PR, Wientroub S, Cannon RO III, Wahl LM. Raloxifene mediated increase in matrix metalloproteinase-1 production by monocytes. Arteriosclerosis, Thrombosis and Vascular Biology. 2001; 21(8): 1265-1268. doi: 10.1161/hq0801.095083
21. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Elgazi A, Ben-Ami M. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia American Heart Journal. 2003; 145(2): 356(e7). doi: 10.1067/mhj.2003.115
22. Blum A, Lang N, Peleg A, et al. effects of oral soy protein on the endothelial function of postmenopausal women with mild hypercholesterolemia. Clinical Investigation Journal. 2003; 26(1): 20-26.
23. Blum A, Safori G, Hoffman M, Hous N, Lupovitch S The prognostic value of High-sensitive C-reactive Protein and Cardiac Troponin T in patients with angina pectoris without ECG changes. European Journal of Internal Medicine. 2003; 14(5): 310-314. doi: 10.1016/S0953-6205(03)00099-2
24. Blum A, Peleg A, Weinberg M. Anti-Cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis. Clinical and Experimental Medicine. 2003; 3(3): 157-160. doi: 10.1007/s10238-003-0019-7
25. Blum A, Schneider DJ, Sobel BE, Dauerman H. Endothelial Dysfunction and Inflammation after Percutaneous Coronary Intervention. American Journal of Cardiology. 2004; 94: 1420-1423. doi: 10.1016/j.amjcard.2004.07.146
26. Aggarwal A, Blum A, Schneider DJ, Sobel BE, Dauerman H. Soluble CD40 Ligand is an Early Initiator of Inflammation after Coronary Intervention Coronary Artery Disease. 2004; 15(8): 471-475.
27. Blum A, Massachi R, Miller H. The Predictive Value of the White Blood Cell Count on the Success of Primary Percutaneous Intervention (PCI) of the Left Anterior Descending (LAD) Artery in Patients Admitted with Acute Anterior Wall Myocardial Infarction. European Journal of Internal Medicine. 2004; 15(3): 176-180. doi: 10.1016/j.ejim.2004.01.019
28. Burke M, Furman A, Hoffman M, Marmor S, Blum A, Yust I. Lung cancer in patients with HIV infection: is it AIDS-related?. HIV Med. 2004; 5(2): 110-114. doi: 10.1111/j.1468-1293.2004.00196.x
29. Blum A, Reisner S, Y Farbstein. Transesophageal Echocardiography (TEE) vs Transthoracic Echocardiography (TTE) in assessing cardio-vascular sources of emboli in patients with acute ischemic stroke. Medical Science Monitor. 2004; 10(9): CR521-CR523.
30. Blum A, Hadas V, Burke M, Yust I, Kessler A. Viral load of the human immunodeficiency virus (HIV) could be an independent risk factor for endothelial dysfunction. Clinical Cardiology. 2005; 28: 149-153. doi: 10.1002/clc.4960280311
31. Blum A, Peleg A, Merei M, et al. High-sensitivity C-Reactive Protein (hs-CRP) level in patients with Sickle Cell Anemia. HAEMA. 2005; 8(3): 462-464.
32. Blum A, Yeganeh S Peleg A, et al. Endothelial function in patients with sickle cell anemia during and after sickle cell crises. Journal of Thrombosis and Thrombolysis. 2005; 19(2): 83-86. doi: 10.1007/s11239-005-1377-7
33. Blum A, Khazim K, Merei M, Peleg A, Blum N, Weispapir V. The Stroke Trial - Can We Predict Clinical Outcome of Patients with Ischemic Stroke by Measuring Soluble Cell Adhesion Molecules (CAM)?. European Cytokine Network. 2006; 17(4): 295-298. doi: 10.1684/ecn.2006.0048
34. Blum A, Mashiach-Eizenberg M, Simsolo C. Diagnosing Pulmonary Emboli: Importance of the Clinical Assessment. Medical Hypotheses and Research 2006; 3(1): 623-628.
35. Blum A, Merei M, Karem A, et al. Effects of Tomatoes on the Lipid Profile. Clinical and Investigative Medicine. 2006; 29(5): 298-300.
36. Blum A, Merei M, Khazim K, Peleg A, Blum N. Tomato-Rich (Mediterranean) Diet does not modify inflammatory markers. Clinical and Investigative Medicine. 2007; 30(2): 100-104.
37. Blum A, Kryuger K, Mashiach-Eizenberg M, et al. Periodontal care may improve endothelial function. European Journal of Internal Medicine. 2007; 18(4): 295-298. doi: 10.1016/j.ejim.2006.12.003
38. Blum A, Peleg A, Front E. Periodontal Care may Improve Vascular Inflammation. Clinical and Investigative Medicine. 2007; 30(3): 114-117.
39. Blum A, Hijazi I, Mashiach-Eizenberg M, Blum N. Homocysteine (Hcy). Follow-Up Study Clinical and Investigative Medicine. 2007; 30(1): 21-25.
40. Lipponcott MF, Carlow A, Desai A, et al. Relation of Endothelial Function to Cardiovascular Risk in Women with Sedentary Occupations and without known Cardiovascular Disease. American Journal of Cardiology. 2008; 102(3): 348-352. doi: 10.1016/j.amjcard.2008.03.069
41. Lipponcott MF, Desai A, Zalos G, et al. Predictors of Endothelial Function in Employees with Sedentary Occupations in a Worksite Exercise Program. American Journal of Cardiology. 2008; 102(7): 820-824. doi: 10.1016/j.amjcard.2008.05.020
42. Blum A, Costello R, Csako G, et al. The Variability of High-Sensitivity C-Reactive Protein levels in Stable Angina Pectoris Coronary Artery Disease Patients Israel. Medical Association Journal. 2009; 11: 602-605.
43. Desai A, Glaser A, Liu D, et al. Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Thrombosis and Vascular Biology. 2009; 29(1): 121-127.doi: 10.1161/ATVBAHA.108.174573.
44. Blum A, Childs R, McCoy P, Csako G. Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease. Cytotherapy. 2009; 11(8): 1016-1019. doi: 10.3109/14653240903131640.
45. Blum A, Blum N. Are men and women created equal?. Gender Medicine. 2009; 6(3): 410-418,
46. Liu D, Glaser AP, Patibandla S, et al. Transcriptional profiling of CD133+ cells in coronary artery disease and effects of exercise on gene expression. Cytotherapy. 2011; 13: 227-236. doi: 10.3109/14653249.2010.491611.
47. Blum A, Vaispapir V, Haiek S. Inflammatory Response in the first 48 hours of Acute Ischemic. Stroke Journal of Neurology Research. 2011; –1(1): 16-21.
48. Blum A, Sirchan R, Abu-Shkara F, Keinan-Boker L. Abdominal Circumference and Recurrent Hospitalizations May Affect the Clinical Outcome of Patients with Acute Heart Failure Experimental & Clinical Cardiology. 2011; 16(2): 40-42.
49. Blum A, Simsolo C, Haiek S, Sirchan R. Obesity paradox in patients with chronic obstructive pulmonary disease (COPD). Israel Medical Association Journal. 2011; 13: 672-675.
50. Blum A, Sirchan R, Keinan-Boker L. Gender Effects on Acute Heart Failure. International Journal of Clinical Medicine. 2011; 2(3): 254-259.
51. Blum A, Zarqh O, Peleg A, et al. Vascular Inflammation and Endothelial Dysfunction in Fracture Healing. The American Journal of Orthopedics. 2012; 41(2): 87-91.
52. Salomon A, Blum A, Peleg A, Lev E, Leshem-Lev D, Hasin Y. Endothelial Progenitor Cells Are Suppressed in Anemic Patients with Acute Coronary Syndrome. The American Journal of Medicine. 2012; 125(6): 604-611. doi: 10.1016/j.amjmed.2011.10.025
53. Blum A, Tamir S, Mualem K, Ben-Shushan R, Keinan-Boker L, Paritsky M. Endothelial Dysfunction is Reversible in Helicobacter Pylori Positive Subjects. The American Journal of Medicine. 2011; 124(12): 1171-1174. doi: 10.1016/j.amjmed.2011.08.015.
54. Blum A, Vaispapir V, Rizak S, et al. Endothelial Dysfunction and Pro-Coagulant Activity in Acute Ischemic Stroke. Journal of Vascular and Interventional Neurology. 2012; 5(1): 33-39.
55. Blum A, Socea D, Ben Shushan RS, Keinan-Boker L, Naftali M, Tamir S. Decrease in Vascular Endothelial Growth Factor and in Systemic Inflammatory Markers Predicts the Development of Diabetic Proliferative Retinopathy. Eur Cytokine Netw. 2012; 23(4): 158-162. doi: 101684/ecn20120321
56. Blum A, Tamir S, Hazzan D, et al. Gender Effect on Vascular Inflammation Post Bariatric Surgery for Weight Loss. Eur Cytokine Netw. 2012; 23(4): 154-157. doi: 101684/ecn20120318
57. Blum A, Socea D, Ben Shushan RS, Keinan-Boker L, Segol G, Tamir S. Clinical Characteristics of Diabetic Patients at Different Stages of Diabetic Retinopathy. Eur Cytokine Netw. 2012; 23(4): 158-162.
58. Blum A, Tamir S, Hazzan D, et al. Gender Effect on Vascular Responsiveness Post Bariatric Surgery Central. European Journal of Medicine. 2013; 8(5): 531-538. doi: 10.2478/s11536-012-0138-1
59. Blum A, Simsolo C, Sirchan R. Vascular Responsiveness in Patients with Chronic Obstructive Pulmonary Disease (COPD). Eur J Intern Med. 2014; 25(4): 370-373 doi: 10.1016/j.ejim.2013.03.017
60. Angelli G, Buller HR, Cohen A, et al. Oral apizaban for the treatment of acute venous thromboembolism. NEJM. 2013 369(9): 799-808 doi: 10.1056/NEJMoa1302507.
61. Blum A, *Ginat-Maimon L, Geron N, Ben Ami M, Tamir S. Inhibition of inflammation may enhance nitric oxide availability in patients undergoing bariatric surgery for weight loss. Journal of Internal Medicine. 2015; 278(4): 401-409. doi: 10.1111/joim.12379
62. *Premer C, *Blum A, Bellio M, et al. Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells. eBioMedicine. 2015; 2(5): 467-475. doi: 10.1016/j.ebiom.2015.03.020
63. Blum A, Zouabi A, Kuria S, Blum N. High serum lactate level may predict death within 24 hours Cent. Eur J of Medicine. 2015; 10: 319-323.


1. Blum A, Ben-Yehuda A. Acute reversible renal failure complicating acute hepatitis. A Harefua. 1990; 118 (7): 388.
2. Ben-Yehuda A, Blum A, Lichowitzki G, Flusser D, Tur-Kaspa R. Chlorpromazine induced liver and bone marrow granulomatous associated with agranulocytosis. Isr J Med Sci. 1990; 26: 449-451.
3. Burstein M, Blum A, Heiman A. Non-thrombocytopenic purpura induced by cefoxitin. Drug Intel & Clin Pharm. 1990; 24: 206.
4. Blum A. Ofloxacin induced acute severe hepatitis. South Med J. 1991; 84(9): 1158.
5. Blum A, Nusem I, Sharon S. Drug interaction: Rifampine & Corticosteroides. Harefua. 1991; 120(12): 734-736.
6. Blum A, Lubezki A, Sclarovski S. Black scorpion sting: two case reports and review of the literature. Clinical Cardiology. 1992; 15(5): 377-378. doi: 10.1002/clc.4960150514
7. Blum A, Ezra D. Severe GIT bleeding induced by a probable hydroxycoumarine-bezafibrate interaction. Israel Journal of Medical Sciences. 1992; 28: 47-49.
8. Blum A, Miller H. The Fleeting Nature of the LIMA. Gazzeta Medica Italiana. 1997; 156: 17-18.
9. Blum A, Jawabreh S, Gumanovsky M, Soboh S. Scorpion Envenomation with Myocardial Damage. The Israel Medical Association Journal. 2000; 2: 318-319.
10. Kurzbaum A, Simsolo C, Ludmilla K, Blum A. Toxic delirium due to Datura Stramonium. Israel Medical Association Journal. 2001; 3(7): 538-539.
11. Vaispapir V, Blum A, Soboh S, Ashkenazi H. West Nile Virus (WNV) Meningoencephalitis with Optic Neuritis. Archives of Internal Medicine. 162(5): 606-7, 2002
12. Blum A, Ashkenazi H, Haromankov I, Khazim K, Sheiman J. Cardiac manifestations of Fabrys disease; Report of a case with 1st degree AV block and restrictive physiology. Southern Medical Journal. 2003; 96(2): 212-213.
13. Blum A, Tatour I, Simsolo C. Vipera Palestinae Envenomation Induced Bradycardia European Journal of Internal Medicine. 2004; 15(2): 134. doi: 10.1016/j.ejim.2004.01.009
14. Simsolo C, Tatour I, Vigder F, Blum A. Pulmonary Hypoplasia. Israel Medical Association Journal. 2004; 6: 494-495.
15. Leikin A, Merei M, Dahan E, Blum A. Coumadine Induced Hepatitis. European Journal of Internal Medicine. 2005; 16(1): 61-62. doi: 10.1016/j.ejim.2004.08.011
16. Dahan E, Simsolo C, Merei M, Vigder F, Tatour I, Blum A. Varicella-Zoster infection and pulmonary complications. European Journal of Internal Medicine. 2005; 16(6): 449-450. doi: 10.1016/j.ejim.2005.02.011
17. Khazim K, Simsolo C, Nahir M, Vigder F, Blum A. Periaortisis – the importance of an early diagnosis. Israel Medical Association Journal. 2006; 8(2): 140-141.
18. Blum A, Abboud W, Shajrawi I, Tatour I. Prolonged Fever due to Silicone Granulomatosis. Israel Medical Association Journal. 2007; 9: 1-2.
19. Blum A, Simsolo C, Elhanan E, Tatour I. Hyponatremia and Confusion Caused by Pregabalin. Israel Medical Association Journal. 2009; 11: 699-700.
20. Blum A, Shalabi R, Brofman T, Shajrawi I. Cardiac manifestations of Ulcerative Colitis. Israel Medical Association Journal. 2009; 9: 764-765.
21. Blum A, Podvitzky O, Shieman J, Khasin M. Reversal of 1st degree AV block in Fabry Disease. Archives of Internal Medicine. 2009; 169(20): 1925-1926.
22. Blum A, Shalabi R. Osler Weber Rendu and Heart Failure. Clinical Medicine Insights: Cardiology. 2009; 3: 121-123.
23. Blum A, Simsolo C. Acute Unilateral Sensorinueral Hearing Loss due to H1N1 Infection. Israel Medical Association Journal. 2010; 12: 450.
24. Blum A, Podvitzky O, Shalabi R, Simsolo C. H1N1 infection manifested as an acute pancreatitis. Israel Medical Association Journal. 2010; 12: 640-641.
25. Atlas I, Kruger C, Blum A. Superior Vena Cava Syndrome in a Patient with Severe. Thrombocytopenia. 2010; 103(11): 885-886.
26. Blum A, Gaban W, Slonimsky G, Simsolo C. Metfromin induced hemolysis. Israel Medical Association Journal. 2011; 13: 444-445.
27. Blum A. Angioedema induced by angiotensin converting enzyme inhibitors (ACEi). Journal of Clinical Case Reports. 2012; 2:10
28. Blum A. Erythrodermic Pustular Psoriasis Triggered by Subcutaneous Flu Vaccine. Journal of Clinical Case Reports. 2013; 3: 2 doi: 10.4172/2165-7920.1000255
29. Blum A, Gershovitz M, Jerdev M, Hasarma S. Sub Acute Thyroiditis in a Case of West Nile Virus (WNV) Infection. J Clin Case Reports. 2013; 3: 11. doi: 10.4172/2165-7920.1000318
30. Blum A, Nazzal S, Peretz A. Smartphone expedites parasitology diagnosis. Israel Medical Association Journal. 2014; 16(7): 463.
31. Blum A, Arabi A. Churg Strauss syndrome and migratory polyarthritis. J Clin Case Reports. 2014; 4: 8. doi: 10.4172/2165-7920.1000405
32. Blum A, Ovadia M, Rosen G, Simsolo C. Immediate Recovery of an Ischemic Stroke Following Treatment with Intravenous Thiamine (vitamin B1). Israel Medical Association Journal. 2014; 16(8): 518-519.
33. Blum A, Nazzal S, Paritzky M. Virchow node and gastric cancer – clinical diagnosis is still important. J Clin Case Reports. 2014; 4:9 doi: 10.4172/2165-7920.1000412
34. Shoher S, Yeganeh S, Blum A. Plasma cell leukemia. J J Hemato. 2015, 1(3): 015.
35. Blum A, Shoher S, Yeganeh S. Botanic Selective estrogen receptor modulators (SERMs) and Venous Thrombo Emboli (VTE). J J Hemato. 2015; 1(3): 018.


1. Blum A, Shalit M. Anaphylactic reaction – update. Harefua. 1989; 117(12): 449-452.
2. Blum A, Kraus Y. Postpartum thyroid dysfunction. Harefua. 1990; 118 (4): 226-228, doi: 10.1001/archinte.1986.00360190060005.
3. Blum A. Hurthle cell thyroid neoplasms. Harefua. 1990; 119(12): 451.
4. Blum A, Shalit M. Tilade (nedocromil sodium): a new antiasthmatic agent. Harefua. 1990; 118(6): 353-354.
5. Burstein M, Blum A, Heiman A. Non-thrombocytopenic purpura induced by cefoxitin. Drug Intel & Clin Pharm. 1990; 24: 206.
6. Blum A., Nusem I., Sharon S. Drug interaction: Rifampine & Corticosteroides. Harefua. 1991; 120(12): 734-736.
7. Blum A., Engelhard D. Gancyclovir - the drug of choice for CMV infection. Harefua. 1991; 121(7, 8): 255-259.
8. Blum A. Rheumatic fever - an immunogenetic disease. Harefua. 123(1, 2):40-2, 1992.
9. Blum A. The influence of interleukin 1 on blood cells and the vascular bed. Harefua. (Editorial) 124 (3): 173-174, 1993.
10. Blum A. Immunologic mechanisms in atherosclerosis. Harefua. 1994; 127(10): 401-402.
11. Blum A, Aravot D. Heart transplantation - an update. Clinical Cardiolog. 19: 930-8, 1996.
12. Blum A., Miller H. The role of inflammation in atherosclerosis. Israel Journal of Medical Sciences. 1996; 32(11): 1059-1065.
13. Blum A., Miller H. Role of cytokines in heart failure. American Heart Journal. 1998; 135:181-186.
14. Blum A., Cannon RO III. Effects of Oestrogens and Selective Oestrogen Receptor Modulators on Serum Lipoproteins and Vascular Function. Current Opinion in Lipidology. 1998; 9: 575-586.
15. Blum A., Miller H. The Effects of L-arginine on Atherosclerosis and Heart Disease. Acute Cardiac Care. 1999; 2(2): 97-100.
16. Blum A., Cannon RO III. Hormone Replacement Therapy for Prevention or treatment of Atherosclerosis in Postmenopausal Women: Promises, Controversies, and Clinical Trials. American Journal of Geriatric Cardiology. 2000; 9(2): 81-88. doi: 10.1111/j.1076-7460.2000.80013.x
17. Blum A., Miller H. Major Histocompatibility Complex (MHC) and Inflammation. Southern Medical Journal. 2000; 93(2): 169-172.
18. Blum A, Shapira Y, Yagne S, Rabinkov M. Mitral Valve Prolapse and Thromboembolic Events. Israel Medical Association Journal. 2001; 3: 282-283.
19. Blum A., Miller H. L-Arginine – What Have We Learned So Far?. Journal of the Israel Heart Society. 2001; 11(2): 4-8.
20. Blum A, Cannon R.O.III. -arginine for the prevention and treatment of coronary artery disease. Coronary Artery Disease. Review in Depth. 2001; 12: 535-539.
21. Blum A, Cannon R.O.III. The Effects of Raloxifene (Selective Estrogen Receptor Modulator) on the Endothelium-Dependent Vasodilation and the Vascular Inflammation in Postmenopausal Women and Hypercholesterolemic Men. Annals of the New York Academy of Sciences. 2001; 949: 168-174.
22. Blum A, Sheiman J, Hasin Y. Leukocytes in Acute Myocardial Infarction. Israel Medical Association Journal. 2002; 4(11): 1060-1065.
23. Blum A. Beneficial Effects of Soy Protein on Endothelium-Dependent Vasodilation - Future Directions. Israel Medical Association Journal. 2003; 5(1): 56-58.
24. Blum A, Shenhav M, Baruch R, Hoffman M. Endothelium Dysfunction in Preeclampsia and Eclampsia: Current Etiology and Future Non- Invasive Assessment. Israel Medical Association Journal. 2003; 5: 724-726.
25. Blum A., Yagene S. The Role of T-Lymphocyte Subpopulations in Acute Myocardial Infarction. European Journal of Internal Medicine. 2003; 14(7): 407-410. doi: 10.1016/j.ejim.2003.09.002
26. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis. 2004; 172(1): 1-6. doi: 10.1016/S0021-9150(03)00164-3
27. Blum A., Simsolo C, Hasin Y. 3-Hydroxy 3-Methyl Glutaryl Coenzyme A (HMG-CoA) reductase inhibitors (Statins), atherosclerosis and coronary syndromes. Atherosclerosis. 175(1): 1-5, 2004. doi: 10.1016/j.atherosclerosis.2003.12.024
28. Blum A., Simsolo C. The Anti-Phospholipid Syndrome and Endothelial Function. Israel Medical Association Journal . 2004; 6: 556-558.
29. Blum A., Merei M, Wirsansky I, Ben-Arzi S. The Beneficial Effects of Tomatoes. European Journal of Internal Medicine. 2005; 16(6): 402-404. doi: 10.1016/j.ejim.2005.02.017
30. Blum A., Tatour I, Merei M, Khazim K, Simsolo C. Gallstones in pregnancy and their complications: Postpartum Acute Pancreatitis and Acute Peritonitis. European Journal of Internal Medicine. 2005; 16(7): 473-476. doi: 10.1016/j.ejim.2005.03.005
31. Blum A, Front E. Periodontitis Endothelial Dysfunction and Atherosclerosis Vascular Disease Prevention. 2006; 3(1): 57-60.
32. Blum A. Red blood cell vesicles and the endothelium. HAEMA. 2006; 9(1): 149-151.
33. Blum A. Soluble CD40 Ligand and Atherosclerosis: Linking Thrombosis and Inflammation HAEMA. 2006; 9(3): 361-366.
34. Blum N, Blum A. Beneficial Effects of Sauna Bathing for Heart Failure Patients Experimental and Clinical Cardiology. 12(1): 29-32, 2007.
35. Blum A. The Possible Role of Red Blood Cell Microvesicles in Atherosclreosis European Journal of Internal Medicine. 2009; 20(2): 101-105. doi: 10.1016/j.ejim.2008.06.001
36. Blum A. Heart Failure – New Mechanistic Insights. Israel Medical Association Journal. 12: 105-111, 2009.
37. Blum A. Immunological Mediated Therapies for Heart Failure. Israel Medical Association Journal. 2009; 11: 301-305..
38. Blum A. Treating Heart Failure with Nitric Oxide Enhancement Vehicle - Sildenafil Congestive Heart Failure. 2009; 15(4): 181-185.
39. Blum A, Shamburek R. The Pleiotropic Effects of Statins on Endothelial Function, Vascular Inflammation. Immunomodulation and Thrombogenesis Atherosclerosis. 203: 325-330, 2009. doi: 10.1016/j.atherosclerosis.2008.08.022.
40. Blum A. The Forgotten Side Effect of Thiazides. American Journal of Pharmacology and Toxicology. 2009; 4(4): 174-176. doi: 10.3844/ajptsp.2009.174.176
41. Blum A, Balkan W, Hare JM. Advances in cell-based therapy for peripheral vascular disease. Atherosclerosis. 223(2): 269-277, 2012. doi: 10.1016/j.atherosclerosis.2012.03.017.
42. Blum A, Gomes SA, Hatzistergos KE. Osteopontin function and interaction with vascular calcification and atherosclerosis. Journal of Applied Medical Sciences. 2012; 1(2): 1-13.
43. Blum A, Nahir M. Future non-invasive imaging to detect vascular plaque instability and subclinical non-obstructive atherosclerosis. J Geriatr Cardiol. 2013; 10(2): 178-185. doi: 10.3969/j.issn.1671-5411.2013.02.008.
44. Blum A. HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells—New mechanistic insights of atherosclerosis. Bio Factors. 2014; 40(3): 295-302. doi: 10.1002/biof.1157
45. Blum A, Nazzal S, Blum N. Mechanistic pathways of atherosclerosis – vasa vasorum, endothelial progenitor cells – and the effects of HMG-CoA reductase inhibitors. Journal of Disease Markers. 2014; 1(1): 6-12.
46. Blum A. Endoethelial Progenitor Cells are affected by Medications and Estrogen IMAJ. 2015; 17: 578-580.


1. Blum A., Sclarovsky S., Rechavia E. Infective myocardial infarction - a reply. Chest. 1994; 105(5): 1618-1619.
2. Blum A. The involvement of T-lymphocytes in unstable angina pectoris. Harefua. 1994; 127(5-6): 213-214.
3. Blum A, Shohat B.CD4 lymphopenia induced by streptokinase. Circulation. 1995; 91(6): 1899.
4. Blum A. Interleukin 1 in acute myocardial infarction. The Lancet. 1996; 347: 56.
5. Blum A. Atherosclerosis as an immunological process. Harefua. 1996; 130 (2): 140.
6. Blum A, Miller H. Serum sIL-2R in AMI and in acute heart failure. Circulation. 1997; 95(6): 1670-1671.
7. Blum A. Lymphocytes in heart disease. Circulation. 1998; 98 (15): 1587. doi: 10.1161/01.CIR.98.15.1587.c
8. Blum A. Inflammatory response in unstable angina. Circulation. 1999; 100(19): e97. doi: 10.1161/01.CIR.100.19.e98
9. Blum A. Anti CMV antibodies and coronary artery disease. Circulation. 1999; 100(25): e138. doi: 10.1161/01.CIR.100.25.e138
10. Blum A., Miller H. The effects of L-arginine on Atherosclerosis, Smoking-Induced Vascular Damage, and Impotance. Internal Medicine Review. 40: 27-32, 2002
11. Blum A. White Blood Cell (WBC) and the Coronary Anatomy in Acute Coronary Events. The American Journal of Cardiology. 2005; 95(1): 159-160.
12. Blum A. Effects of soy protein sipping oral inflammation markers in postmenopausal women with mild hypercholesterolemia.2005
13. Blum A, Costello R, Zalos G, Quan M, Csako G, Cannon RO III. Variability in levels of C-reactive protein over brief intervals in patients with coronary artery disease. JACC. 2008; 51 (10): A365.
14. Desai A, Lippincott M, Blum A, et al. Brief periods of daily exercise at the workplace along with lifestyle and nutritional guidance improve cardiovascular profile of sedentary employees. JACC. 2008; 51 (10): A365.
15. Blum A, Costello R, Zalos G, Quan M, Csako G, Cannon RO. Fluctuations in Levels of C-Reactive Protein Over Brief Intervals in Patients with Coronary Artery Disease. JACC. 2008; 51(10): A365.
16. Blum A. The vulnerable patient; not the vulnerable plaque…Israeli medical. Association Journal. 2008; 10(12): 909.
17. Blum A. Cytokines and coronary artery disease. Israeli Medical Association Journal. 2009; 11(1): 65.
18. Blum A, Podovitzky O, Nuri J, Khasin M. Reversal of 1st degree AV block in Fabry Disease – response letter to the Editor. Archives of Internal Medicine. 2010; 170(6): 573-574.
19. Blum A. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept – there could be light in the end of the tunnel.
20. European Journal of Internal Medicine. 2011; 22(3): e15 doi: 10.1016/j.ejim.2011.02.010.
21. Blum A. Pulmonary Hypertension in Sickle Cell Disease. New England Journal of Medicine. 2011; 365: 1646-1647 doi: 10.1016/j.amjmed.2004.03.034
22. Blum A. Helicobacter pylori and atherosclerosis. IMAJ. 2015; 17: 396.